Company: SMNR
Filing Date: 2025-04-02
Form Type: 10-K
Source: 0001213900-25-027319
Chunk: 1131

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-04-02
Form: 10-K
Item: Item 7A
Chunk 1131
---
. in New York. Before going to New York, Dr. Chang worked at Kamakura
Corporation in Hawaii as a derivative and risk modeler. Mr. Chang has also been an independent director of Scienjoy Holding Corporation
since May 2020 and on the advisory board of Aquamarine Investment Partners Ltd. since 2015. Dr. Chang earned a Ph.D. in Soil Physics and
an MBA from the University of Hawaii at Manoa. He also earned an M.S. degree from Academia Sinica and a B.S. degree from Nanjing Agricultural
University.

24

Jim Mao, Director

Mr. Mao has served as our director since April 2022. Since February
2020, Mr. Mao has served as a founding and managing partner of Citta Capital (“Citta”), a firm focused on investing in
early growth stage technology startups in Enterprise/SaaS, Blockchain, ESG, AI applications, cloud computing and healthcare technology
since 2020. As of December 31, 2024, Citta has a diverse portfolio of companies that includes Kintsugi (a leading AI based mental
health diagnostics company), Openprise, Inc. (automation solutions), Sequoia Games, Inc. (combining the latest technology with professional
sports), SetPoint (clinical stage neuro treatment), Zeit Medical (early heart stroke detection with FDA breakthrough destination), and
Ryu Games (Web3.0 Gamify). Prior to that, from March 2015 to February 2020, Mr. Mao was a Partner at WestSummit Capital (“WSC”),
a leading global technology growth capital venture firm. He has also co-authored five U.S. patents. He has over 20 years of working experience
in private equity and technology sectors, including enterprise software, Internet, mobile applications, digital media, intelligent hardware,
advanced manufacturing/ materials, medical devices and clean technology.

Kevin D. Vassily, Director

Mr. Vassily has served as our director and Chair of the Audit
Committee since April 2022. Mr. Vassily has extensive working experience as a senior management team member serving private and public
companies. In January 2021, he was appointed Chief Financial Officer, and since March 2021, is a member of the board of directors of iPower
Inc. (Nasdaq: IPW), a leading online hydroponic equipment retailer and supplier. Mr.